Matinas BioPharma Holdings, Inc. (MTNB) — Stock Valuation & Research

Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts. This sophisticated LNC delivery system leverages lipid nano-crystals to transport a diverse array of therapeutic agents, including small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its primary experimental drug, LYPDISO, is a proprietary, prescription-grade omega-3 free fatty…

MTNB key statistics

Price$1.21
Market cap$516,766
SectorHealthcare
IndustryBiotechnology
ExchangeAMEX
52-week range0.966-20.1
Beta1.7

Explore MTNB's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.